Cargando…

Vitamin K Deficiency Induced by Warfarin Is Associated With Cognitive and Behavioral Perturbations, and Alterations in Brain Sphingolipids in Rats

Initially discovered for its role in blood coagulation, there is now convincing evidence that vitamin K (VK) has important actions in the nervous system. In brain, VK is present in the form of menaquinone-4 (MK-4), a byproduct of the main dietary source, phylloquinone. It contributes to the biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamadon-Nejad, Sahar, Ouliass, Bouchra, Rochford, Joseph, Ferland, Guylaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054920/ https://www.ncbi.nlm.nih.gov/pubmed/30061825 http://dx.doi.org/10.3389/fnagi.2018.00213

Ejemplares similares

Exploratory analysis of covariation of microbiota-derived vitamin K and cognition in older adults
por: McCann, Angela, et al.
Publicado: (2019)

Vitamin K Antagonists and Cognitive Decline in Older Adults: A 24-Month Follow-Up
por: Brangier, Antoine, et al.
Publicado: (2018)

Dietary Vitamin K Intake Is Associated with Cognition and Behaviour among Geriatric Patients: The CLIP Study
por: Chouet, Justine, et al.
Publicado: (2015)

Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
por: Riley, R T, et al.
Publicado: (2001)

Sphingolipid Metabolism Perturbations in Rett Syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2019)

Colon Cancer and Perturbations of the Sphingolipid Metabolism
por: Machala, Miroslav, et al.
Publicado: (2019)

Effects of Obesity on Warfarin Reversal With Vitamin K
por: Luc, Stanley A., et al.
Publicado: (2019)

Sphingolipid serum profiling in vitamin D deficient and dyslipidemic obese dimorphic adults
por: Al-Daghri, Nasser M., et al.
Publicado: (2019)

Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats
por: Zayed, Aref, et al.
Publicado: (2020)

CERT1 mutations perturb human development by disrupting sphingolipid homeostasis
por: Gehin, Charlotte, et al.
Publicado: (2023)

Publisher Correction: Sphingolipid serum profiling in vitamin D deficient and dyslipidemic obese dimorphic adults
por: Al-Daghri, Nasser M., et al.
Publicado: (2020)

Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023)

Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy
por: Park, Ji Na, et al.
Publicado: (2015)

Untargeted Plasma Lipidomics Reveal Perturbed Metabolites of Glycerophospholipids, and Sphingolipids in Moderate-to-Severe Acne
por: Zhang, Deng, et al.
Publicado: (2023)

Altered Leukocyte Sphingolipid Pathway in Breast Cancer
por: Maia, Larissa P., et al.
Publicado: (2017)

Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases
por: Pujol-Lereis, Luciana M.
Publicado: (2019)

Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
por: Khansari, Nakisa, et al.
Publicado: (2022)

The Equilibria of Sphingolipid-Cholesterol and Sphingolipid–Sphingolipid in Monolayers at the Air–Water Interface
por: Petelska, Aneta Dorota, et al.
Publicado: (2012)

Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine
por: Armitage, Emily G., et al.
Publicado: (2018)

Vitamin K Antagonist Warfarin for Palliative Treatment of Metachromatic Leukodystrophy, A Compassionate Study of Four Subjects
por: Assadi, Mitra, et al.
Publicado: (2012)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Publicado: (2020)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
por: Huang, Huei‐Kai, et al.
Publicado: (2020)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
por: Lee, Hyun-Jung, et al.
Publicado: (2023)

Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer
por: Jiang, Yixing, et al.
Publicado: (2013)

The Role of the Gut Microbiome in Diet and Exercise Effects on Cognition: A Review of the Intervention Literature
por: Koblinsky, Noah D, et al.
Publicado: (2022)

Purpura Caused by Vitamin K Deficiency
por: Laha, P. N., et al.
Publicado: (1946)

Vitamin K Deficiency Bleeding in Infancy
por: Araki, Shunsuke, et al.
Publicado: (2020)

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids
por: Othman, Alaa, et al.
Publicado: (2023)

Rice Stripe Virus Infection Alters mRNA Levels of Sphingolipid-Metabolizing Enzymes and Sphingolipids Content in Laodelphax striatellus
por: Jiao, Wen-Juan, et al.
Publicado: (2017)

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
por: Golbin, Léonard, et al.
Publicado: (2017)

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
por: Lee, Hsin‐Fu, et al.
Publicado: (2019)

Risk of recurrent stroke for Asian stroke patients treated with non-vitamin K antagonist oral anticoagulant and warfarin
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
por: Hammwöhner, Matthias, et al.
Publicado: (2020)

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation
por: Choi, Seong Huan, et al.
Publicado: (2022)

Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
por: Kozieł, Monika, et al.
Publicado: (2020)

Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review
por: Sankar, M J, et al.
Publicado: (2016)

Comprehensive Plasma Metabolomic Analyses of Atherosclerotic Progression Reveal Alterations in Glycerophospholipid and Sphingolipid Metabolism in Apolipoprotein E-deficient Mice
por: Dang, Vi T., et al.
Publicado: (2016)

Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome
por: Li, Juan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnb4fjdjt0lcl4uo88gmm2ad7b